Showing results (1-10 of 575) with videos related to
Sort By:
Pageof 58
Der Internist|November 7, 2019
[Drug treatment of heart failure in chronic kidney disease]Nikolaus MarxCardiovascular Endocrinology & Metabolism|October 25, 2019
Heart failure: an underestimated therapeutic target in diabetesNikolaus MarxCurrent Hypertension Reports|January 16, 2002
Peroxisome proliferator-activated receptor gamma and atherosclerosisNikolaus MarxTrends in Cardiovascular Medicine|March 1, 2008
C-peptide as a mediator of lesion development in early diabetes--a novel hypothesisNikolaus MarxThe Lancet. Diabetes & Endocrinology|November 7, 2020
Guideline recommendations and the positioning of newer drugs in type 2 diabetes careNikolaus Marx, Melanie J Davies, Peter J Grant, et al.Diabetes & Vascular Disease Research|May 1, 2007
Inter-subject differences in constitutive expression levels of the clock gene in manAnthony J Balmforth, Peter J Grant, Eleanor M Scott, et al.Current Pharmaceutical Design|January 31, 2012
Renin-angiotensin-aldosterone system antagonists and the prevention of type 2 diabetes mellitusRobert Stohr, Nikolaus MarxDiabetologia|August 23, 2018
SGLT2 inhibitors: the future for treatment of type 2 diabetes mellitus and other chronic diseasesChristoph Wanner, Nikolaus MarxThe Review of Diabetic Studies : RDS|December 30, 2009
C-Peptide in the vessel wallDaniel Walcher, Nikolaus MarxExperimental Diabetes Research|April 11, 2008
C-Peptide and atherogenesis: C-Peptide as a mediator of lesion development in patients with type 2 diabetes mellitus?Nikolaus Marx, Daniel WalcherPageof 58